Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03496610
Other study ID # Pro00087144
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 25, 2021
Est. completion date February 23, 2023

Study information

Verified date February 2024
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to learn if using a Quadratus Lumborum (QL) plane injection technique (also called a "nerve block") that numbs the nerves going to the abdominal area improve pain control after surgery compared to administration of local anesthetic directly to the surgical incision. The QL block technique uses a numbing solution (local anesthetics) that is injected next to nerves located along muscles in the back to reduce pain. This block will not affect movement in the leg and/or make the legs weak. Some institutions, including Duke, use the QL block for patients having various abdominal surgeries, with the hope of providing good pain relief combined with improved mobility after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date February 23, 2023
Est. primary completion date February 23, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - English speaking - ASA 1-2 patients undergoing living donor nephrectomy Exclusion Criteria: - ASA 3 or 5 - Diagnosis of chronic pain - Daily chronic opioid use (over 3 months of continuous opioid use) - Inability to communicate pain scores or need for analgesia - Infection at the site of block placement - Pregnant women (as determined by standard of care day-of surgery urine bHCG) - Intolerance/allergy to local anesthetics - Weight <50 kg - Suspected or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years - Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance - Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course

Study Design


Intervention

Drug:
Liposomal Bupivicaine
Patient will receive liposomal bupivicaine mixed with non-liposomal bupivicaine directly to wound
Procedure:
QL Block
Patient will receive ultrasound guided QL Block

Locations

Country Name City State
United States Duke University Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Opioid Consumption in Oral Morphine Milliequivalents for the First 24 Hours After Surgery (Defined as 24 Hours After the Anesthesia End Time) 24 hours postoperatively
Secondary Self-reported Numeric Pain Scores on Postoperative Day Seven Pain was measured on a self-reported scale of 0-10, where 0=no pain and 10=worst imaginable pain. Scores were gathered by phone on postoperative day 7. Postoperative day 7
Secondary Worst Bloating Severity in the First Postoperative Week Bloating severity scores were gathered daily by phone interview for the first week postoperatively. Bloating severity was assessed on a scale of 1-5, where 1= not at all severe and 5=very much. The highest severity score reported during the week was collected for this outcome measure. First seven days postoperatively
Secondary Self-reported Ability to Walk for 15 Minutes Without Any Difficulty Within the First Postoperative Week Physical function was assessed by daily phone interview during the first postoperative week. Subjects were asked to assess their ability to go for a walk of at least 15 minute on a scale of 1-5 with 1=unable to do and 5= able to do without any difficulty. For this outcome, the number of subjects who reported being able to go for a walk of at least 15 minutes "without any difficulty" at any time during the first postoperative week is reported. First seven days postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT05465967 - Transmuscular Quadratus Lumborum Block on Post-Operative Analgesia After Total Hip Arthroplasty N/A
Completed NCT03199170 - Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section N/A
Completed NCT03695588 - Quadratus Lumborum Block (QLB) for Pain Relief After Caesarean Section N/A
Not yet recruiting NCT05089994 - Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy N/A
Recruiting NCT05158270 - Erector Spinae Plane Block As Alternative Analgesic Modality in Laparoscopic Cholecystectomy N/A
Recruiting NCT03540537 - A Trial Comparing Quadratus Lumborum Block (QLB) and Paravertebral Block (PVTB) for Postoperative Analgesia in Hepatectomy N/A
Recruiting NCT03328481 - Quadratus Lumborum Block Using Loss-of-resistance Versus Ultrasound-guided Technique N/A
Not yet recruiting NCT04845711 - Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Laparoscopic Cholecystectomy N/A
Enrolling by invitation NCT04822870 - Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section N/A
Completed NCT05950568 - Quadratus Lumborum Block Type III Versus Type II Versus Transversus Abdominis Plane Block in Cesarean Section N/A
Recruiting NCT04670224 - Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery N/A
Recruiting NCT04830280 - Effect Posterior QLB on Atelectasis N/A
Not yet recruiting NCT05416866 - Transversus Abdominis Plane Block Plus Quadratus Lumborum Block or Retrolaminar Block of Multiple Injections for Postoperative Analgesia Following Laparoscopic Colorectal Surgery Phase 4
Completed NCT04963816 - Pediatric Postoperative Analgesia With Quadratus Lumborum Block(QLB) And Dexamethasone As An Adjuvant To Bupivacaine. N/A
Recruiting NCT04402411 - Quadratus Lumborum Block vs Transversus Abdominis Plane Block in Bladder Cancer Surgeries N/A
Not yet recruiting NCT03973398 - Anterior vs. Posterior Quadratus Lumborum Block in Nephrectomy Patients Early Phase 1
Completed NCT05713643 - ESPB vs PVB vs QLB After Pelvi-ureteric Surgeries N/A
Completed NCT03437187 - The Beneficial Effect of Quadratus Lumborum Block After Laparoscopic Cholecystectomy N/A
Recruiting NCT06155968 - Evaluating The Quality of Recovery After Elective Cesarean Section N/A
Not yet recruiting NCT05442905 - Quadratus Lumborum Versus Transversus Abdominis Plane Block Versus Caudal Block for Postoperative Analgesia After Pediatric Inguinal Hernia : Double-Blinded Randomized Trial N/A